Cltn for Competitive Pharma Marketing
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Cltn for Competitive Pharma Marketing
Names of Lobbyists
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Fed Budget & Appropriations,
- Medicare & Medicaid
Most Frequently Disclosed Bills
Bill No. Title H.R.1038 (Unknown) S.623 Access to Life-Saving Medicine Act H.R.5629 Pathway for Biosimilars Act H.R.4296 Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 S.2408 Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 S.1695 Biologics Price Competition and Innovation Act of 2007 H.R.6331 Medicare Improvements for Patients and Providers Act of 2008 H.R.1956 Patient Protection and Innovative Biologic Medicines Act of 2007 S.1505 Affordable Biologics for Consumers Act H.R.6631 Parimutuel Conformity and Equality Act of 2008